News Releases News Releases Year None20212020201920182016 Jul, 29 2021 TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs Jul, 28 2021 TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference Jul, 22 2021 TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021 Jul, 14 2021 TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System Jun, 10 2021 TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021) May, 4 2021 TransMedics Reports First Quarter 2021 Financial Results Apr, 20 2021 TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 Apr, 6 2021 TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 16
News Releases Year None20212020201920182016 Jul, 29 2021 TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs Jul, 28 2021 TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference Jul, 22 2021 TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021 Jul, 14 2021 TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System Jun, 10 2021 TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021) May, 4 2021 TransMedics Reports First Quarter 2021 Financial Results Apr, 20 2021 TransMedics to Report First Quarter 2021 Financial Results on May 4, 2021 Apr, 6 2021 TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 16
Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System
Jun, 8 2021 TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)
